Professor Mimi Tang discusses multi-year follow up from the PPOIT-003 Phase IIb programme and how these data help clarify distinct post-treatment clinical states, including remission and desensitisation, and their implications for durability, adherence, and real-world patient experience once structured therapy is complete. Recent multi-year data from the PPOIT-003 and PPOIT-003LT programmes demonstrate that PRT120 has the potential to deliver […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!